Sabby Management, LLC Co Diagnostics, Inc. Transaction History

Sabby Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 15, 2019	SELL	$0.81 - $1.35 $226,471 - $377,453	-279,595 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.71 - $1.17 $350,551 - $577,669	-493,735 Reduced 63.85%	279,595 $225,000
Q1 2019 May 15, 2019	BUY	$0.96 - $2.24 $742,396 - $1.73 Million	773,330 New	773,330 $820,000

4.29M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $25M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.